Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of May 25
 +1.66 / +1.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 99.00, with a high estimate of 131.00 and a low estimate of 76.00. The median estimate represents a +8.02% increase from the last price of 91.65.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -39.39%
Growthannually -154.26%


Growthquarterly 10.45%
Growthannually 93.81%
Key to the earnings and sales forecast charts.